Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Novavax (NVAX) Starts A New Study on COVID-Flu Combo Jab
05:01pm, Tuesday, 03'rd Jan 2023 Zacks Investment Research
Novavax (NVAX) initiates a mid-stage study evaluating its COVID-19-Influenza combination and standalone influenza vaccines in adults aged 50 through 80 years.
DocuSign and Ford Motor have been highlighted as Zacks Bull and Bear of the Day
02:16pm, Tuesday, 03'rd Jan 2023 Zacks Investment Research
DocuSign and Ford Motor have been highlighted as Zacks Bull and Bear of the Day.
Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
11:20am, Tuesday, 03'rd Jan 2023 Zacks Investment Research
Style Box ETF report for DHS
Wait to Buy the Pfizer Selloff
10:03am, Tuesday, 03'rd Jan 2023
While the broader market is kicking off the new year on a high note, Pfizer Inc. (NYSE:PFE) is clinging close to breakeven.
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
10:00am, Tuesday, 03'rd Jan 2023
NEW YORK--( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the 41
Why The Dogs Of The Dow Strategy Will Likely Succeed In 2023
05:45am, Tuesday, 03'rd Jan 2023
The "Dogs of the Dow" is a strategy of buying the 10 highest yielding stocks in the Dow (or a subset thereof). The yield spread between the Dogs and the Dow as a whole is larger than usual.
2 Relatively Safe Dividend Stocks to Buy Today and Hold Forever
04:00pm, Monday, 02'nd Jan 2023 The Motley Fool
They already have extensive track records of success, and there's even more on the way.
Should You Invest in the Vanguard Health Care ETF (VHT)?
11:20am, Monday, 02'nd Jan 2023 Zacks Investment Research
Sector ETF report for VHT
Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?
11:20am, Monday, 02'nd Jan 2023 Zacks Investment Research
Smart Beta ETF report for DHS
Why BioNTech Was a Sickly Stock This Week
11:50pm, Friday, 30'th Dec 2022 The Motley Fool
The world is trying hard to get past the coronavirus pandemic, and investors are trying hard to get past coronavirus stocks.
COVID-related ICU patients rise to 5-month high above 5,000—are new cases really falling?
06:47pm, Friday, 30'th Dec 2022 MarketWatch
COVID-related hospitalizations, and patients in ICUs keep rising to multi-month highs, suggesting case counts aren't really falling.
100 Best Stocks Of 2022: Oil Stocks And Medicals Shine
06:00pm, Friday, 30'th Dec 2022
Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business
Pfizer's (PFE) Hemophilia B Gene Therapy Meets Study Goal
02:34pm, Friday, 30'th Dec 2022 Zacks Investment Research
Data from a late-stage study shows that treatment with Pfizer's (PFE) hemophilia B gene therapy resulted in a 71% reduction in annualized bleed rate (ABR) compared to standard-of-care treatment.
China COVID cases could double next month, as Merck antiviral gets approval
02:12pm, Friday, 30'th Dec 2022 MarketWatch
China's health service approved an antiviral to treat COVID-19 as one health company estimates the country will see a doubling of its current wave of cases.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
01:50pm, Friday, 30'th Dec 2022 Zacks Investment Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
